Pardeep S. Jhund

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 64 papers. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European Heart Journal(2021)10.1093/eurheartj/ehab499

N/A

4.2DataRank · unranked

154 citations

Pardeep S. Jhund, Inder S. Anand, Hans‐Dirk Düngen, Carolyn S.P. Lam, Marty Lefkowitz +15 more

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2022)10.1161/circulationaha.122.061754

N/A

4.2DataRank · unranked

152 citations

Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai +22 more

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2020.03.002

N/A

4.1DataRank · unranked

117 citations

Muthiah Vaduganathan, Brian Claggett, Michael R. Zile, Inder S. Anand, Milton Packer +15 more

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3750

N/A

2.9DataRank · unranked

67 citations

Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi +12 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3736

N/A

1.9DataRank · unranked

61 citations

Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Zi Michael Miao, Toru Kondo +11 more

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

European Heart Journal(2020)10.1093/eurheartj/ehaa184

N/A

1.9DataRank · unranked

47 citations

Pardeep S. Jhund, Brian Claggett, Milton Packer, J Widimský, Petar Seferović +6 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy

Circulation(2022)10.1161/circulationaha.122.059210

N/A

1.7DataRank · unranked

60 citations

Brian Claggett, Narayana Prasad, Guichu Li, Mayra Volquez, Karola Jering +13 more

Myocardial Infarction in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2020.02.007

N/A

1.7DataRank · unranked

32 citations

Muthiah Vaduganathan, Brian Claggett, Jenine E. John, Akshay S. Desai, Eldrin F. Lewis +13 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

European Heart Journal(2023)10.1093/eurheartj/ehad283

N/A

1.6DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund +15 more

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Journal of the American Heart Association(2021)10.1161/jaha.121.021494

N/A

1.6DataRank · unranked

45 citations

Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai +14 more

Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF

Journal of the American Heart Association(2021)10.1161/jaha.120.019238

N/A

1.6DataRank · unranked

52 citations

Leanne Mooney, Pooja Dewan, Akshay S. Desai, Ninian N. Lang, Martin Lefkowitz +12 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.08.007

N/A

1.5DataRank · unranked

50 citations

Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer +13 more

Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.009

N/A

1.4DataRank · unranked

29 citations

Pooja Dewan, Ersilia M. DeFilippis, Tor Biering‐Sørensen, Kieran F. Docherty, Pardeep S. Jhund +13 more

Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3253

N/A

1.3DataRank · unranked

83 citations

Brian Claggett, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah +11 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.066506

N/A

1.3DataRank · unranked

36 citations

Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Kieran F. Docherty, Akshay S. Desai +13 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007879

N/A

1.1DataRank · unranked

27 citations

Pooja Dewan, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +9 more

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet(2022)10.1016/s0140-6736(22)01429-5

N/A

1.0DataRank · unranked

942 citations

Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez +9 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials

European Journal of Heart Failure(2023)10.1002/ejhf.2909

N/A

1.0DataRank · unranked

22 citations

Mikhail Kosiborod, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Ian J. Kulac +13 more

Relationship of Dapagliflozin With Serum Sodium

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.019

N/A

0.999DataRank · unranked

31 citations

Kieran F. Docherty, Pardeep S. Jhund, Mark C. Petrie, Silvio E. Inzucchi, Lars Køber +12 more

Impact of Multimorbidity on Mortality in Heart Failure with Reduced Ejection Fraction: Which Comorbidities Matter Most? An Analysis of PARADIGM-HF and ATMOSPHERE

European Journal of Heart Failure(2023)10.1002/ejhf.2856

N/A

0.988DataRank · unranked

19 citations

João Pedro Ferreira, Jawad H. Butt, Mark C. Petrie, William T. Abraham, Akshay S. Desai +11 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Heart Failure, Chronic Obstructive Pulmonary Disease and Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from DELIVER

European Journal of Heart Failure(2023)10.1002/ejhf.3000

N/A

0.889DataRank · unranked

26 citations

Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A. de Boer, Silvio E. Inzucchi +8 more

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.065254

N/A

0.805DataRank · unranked

21 citations

Muthiah Vaduganathan, Senthil Selvaraj, Brian Claggett, Zi Michael Miao, Akshay S. Desai +13 more

Finerenone According to Frailty in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.1775

N/A

0.693DataRank · unranked

14 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Chern‐En Chiang, Gerard C.M. Linssen +18 more

Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial

European Journal of Heart Failure(2023)10.1002/ejhf.3043

N/A

0.691DataRank · unranked

16 citations

Mikhail Kosiborod, Brian Claggett, Zi Michael Miao, Muthiah Vaduganathan, Carolyn S.P. Lam +19 more

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.1342

N/A

0.671DataRank · unranked

13 citations

Alvin Chandra, Mikhail Kosiborod, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund +17 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more

Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3383

N/A

0.590DataRank · unranked

18 citations

Alasdair D Henderson, Li Shen, Toru Kondo, Mingming Yang, Ross T. Campbell +17 more

Finerenone and Atrial Fibrillation in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.0848

N/A

0.572DataRank · unranked

17 citations

Alasdair D Henderson, Pardeep S. Jhund, Johann Bauersachs, Ovidiu Chioncel, Brian Claggett +19 more

Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy(2020)10.1093/ehjcvp/pvaa138

N/A

0.568DataRank · unranked

43 citations

Kieran F. Docherty, Naveed Sattar, Neil Mehta, Ankur Kalra, Amy S. Nowacki +6 more

Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF

European Journal of Heart Failure(2020)10.1002/ejhf.1867

N/A

0.557DataRank · unranked

40 citations

Scott D. Solomon, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod +18 more

Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes

NEJM Evidence(2022)10.1056/evidoa2200047

N/A

0.470DataRank · unranked

22 citations

Zachary R. McCaw, Lü Tian, John J.V. McMurray, Pardeep S. Jhund, Hajime Uno +4 more

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2023)10.1161/circulationaha.122.062918

N/A

0.405DataRank · unranked

7 citations

Karola Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian Claggett, Akshay S. Desai +15 more

Finerenone, Chronic Obstructive Pulmonary Disease, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

European Journal of Heart Failure(2025)10.1002/ejhf.3661

N/A

0.397DataRank · unranked

11 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Akshay S. Desai, Carolyn S.P. Lam +12 more

Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics

JAMA Cardiology(2025)10.1001/jamacardio.2025.2551

N/A

0.379DataRank · unranked

9 citations

Pardeep S. Jhund, Alasdair D Henderson, M. Yang, Brian Claggett, Akshay S. Desai +14 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0.373DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure

European Heart Journal(2025)10.1093/eurheartj/ehaf675

N/A

0.373DataRank · unranked

11 citations

Benjamin R. Heywood, Antoni Bayés‐Genís, Ross T. Campbell, Alasdair D Henderson, Pardeep S. Jhund +11 more

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2025)10.1001/jamacardio.2025.0860

N/A

0.353DataRank · unranked

7 citations

Pardeep S. Jhund, Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Maria Pabón +13 more

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2025)10.1016/j.jchf.2025.03.042

N/A

0.325DataRank · unranked

7 citations

John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt +14 more

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF

European Heart Journal - Cardiovascular Pharmacotherapy(2025)10.1093/ehjcvp/pvaf064

N/A

0.104DataRank · unranked

1 citations

Alasdair D Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni +14 more

Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease

European Heart Journal(2024)10.1093/eurheartj/ehae780

N/A

0DataRank · unranked

8 citations

Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty +16 more

Kidney Status and Events Preceding Death in Heart Failure: A Real-world Nationwide Study

medRxiv(2024)10.1101/2024.10.15.24315570

N/A

0DataRank · unranked

0 citations

Caroline Hartwell Garred, Nicholas Carlson, Emil Loldrup Fosbøl, Mariam Elmegaard, Pardeep S. Jhund +5 more

Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM‐HF and PARAGON‐HF

Journal of the American Heart Association(2024)10.1161/jaha.124.037782

N/A

0DataRank · unranked

14 citations

Mingming Yang, Paolo Tolomeo, Toru Kondo, Li Shen, Pardeep S. Jhund +14 more

Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.05.005

N/A

0DataRank · unranked

42 citations

Brian Claggett, Zi Michael Miao, Finnian R. Mc Causland, Inder S. Anand, Akshay S. Desai +13 more

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study

Journal of Clinical Hypertension(2021)10.1111/jch.14269

N/A

0DataRank · unranked

14 citations

Marcus Vinícius Bolívar Malachias, Brian Claggett, Susan Cheng, Kunihiro Matsushita, Amil M. Shah +5 more

Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan

European Journal of Heart Failure(2022)10.1002/ejhf.2722

N/A

0DataRank · unranked

34 citations

Jawad H. Butt, Toru Kondo, Karola Jering, Kieran F. Docherty, Pardeep S. Jhund +16 more

Risk stratification in patients presenting with acute heart failure

European Heart Journal Acute Cardiovascular Care(2021)10.1093/ehjacc/zuab005

N/A

0DataRank · unranked

1 citations

Pardeep S. Jhund, Elke Platz

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Diabetes Care(2025)10.2337/dc25-2540

N/A

0DataRank · unranked

0 citations

Henri Lu, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson +13 more

Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2025)10.1016/j.jchf.2025.102779

N/A

0DataRank · unranked

0 citations

Muthiah Vaduganathan, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson +14 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials

Circulation Heart Failure(2024)10.1161/circheartfailure.124.012514

N/A

0DataRank · unranked

11 citations

Christopher Reeder, Brian Claggett, Pulkit Singh, Emily S. Lau, Shaan Khurshid +14 more

Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3352

N/A

0DataRank · unranked

12 citations

Toru Kondo, Pardeep S. Jhund, Marco A. Alcocer‐Gamba, C. Jan Willem Borleffs, Chern‐En Chiang +17 more

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

European Heart Journal(2023)10.1093/eurheartj/ehad083

N/A

0DataRank · unranked

242 citations

Mark C. Petrie, Pardeep S. Jhund, Naveed Sattar, Akshay S. Desai, Lars Køber +7 more